Barbara Gayle Duncan - Director at Atea Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
AVIR on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Barbara Gayle Duncan since 08 Jan 2025

Holdings reported by Barbara Gayle Duncan for Atea Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 62,750 $185,112 $2.95 20 Jun 2025 Direct
Restricted Stock Units 0 $103,162 $3.49 20 Jun 2025 Direct Common Stock
Stock Option (Right to Buy) 41,200 20 Jun 2025 Direct Common Stock

Transactions reported by Barbara Gayle Duncan for Atea Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.